SOX9 and breast cancer: Consistently, SRY-Box Transcription Factor 9 (SOX9) overexpression in BC cell lines and transgenic SOX9 expression in mammary epithelium caused increased LRP6 and TCF4 expression and Wnt/β-catenin activation [45].